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pital based series could be used as an alternative source to
estimate the global burden of IE.
doi:10.1016/j.ijid.2010.02.1613
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Background: Surgical site infection (SSI) do have a serious
impact on patients undergoing cardiac surgery. This study
was performed to prove if additional preoperative care by
using a microbial sealant can reduce surgical site infection.
Methods: To improve preoperative surgical care two
groups of patients were identiﬁed during thes same period
of time. Between January and August 2007, a control
group (n = 718), receiving standard institutional preopera-
tive preparation and between January and August 2008,the
InteguSeal group (n = 780) who received additionally amicro-
bial sealant prior to sternotomy. Both groups were evaluated
by patients characteristics and a pre-operative risk scores.
End-point of this study was freedom from SSI.
Results: Follow up was 100% completed. The values of
the pre-operative risk score of the control group and the
InteguSeal group was signiﬁcantly different in both groups,
respectively 9.7.± 1.5 and 10.1± 1.8 (p = 0.001).
The clinical end-point, however showed a highly signif-
icant decrease of SSI in the InteguSeal group 1.4% (n = 11)
compared with the control group 4.3% (n = 31), (p < 0.003)
althrough they were at higher risk for SSI.
Conclusion: Thus, the pre-operative risk score for
patients of the InteguSeal group was signiﬁcant higher com-
pared to the control group, there was a highly signiﬁcant
reduction of surgical site infections seen.
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Background: Infective endocarditis(IE) is an important
contributor to mortality and morbidity worldwide. However,
previous work in the global burden of diseases, injuries,and
a
i
ots e57
isk factors(GBD) has not included speciﬁc assessment of
he burden of IE and its sequelea. We aimed to describe
he methdology for a comprehensive assessment of IE bur-
en trends in 21 world regions for 1990-2005 as part of the
urrent GBD 2005 effort.
Methods: A systematic review of published studies, sur-
eys,and other data sources is being conducted in order
o assess the global epidemiology of IE and related dis-
bling sequelae. Cases of IE were deﬁned according to the
uke, modiﬁed Duke, Steckelberg,Von Reyn and modiﬁed
on Reyn. A simpliﬁed model was used for the system-
tic review and it included cure,valve surgery,stroke, and
eath.Electronic databases included.
MEDLINE,EMBASE,LILACK, KoreaMED, AMED, EXTRAMED,
copus and web of science.Only population based studies
ere used to estimte the incidence.
Results: We identiﬁed 121 studies: 21 population-
ased,21 multicenter studies, and 79 hospital cohorts.
ata originated from 40 countries and 2 international
ollaborations. Only 18 population based studies reported
n the incidence of IE/100,000 in 9 countries.Australia(3),
rance (2.2,3), Denmark(2.4,2.7),Italy (3.6), Nether-
ands(1.5,9.6), Sweden(0.39,6.2), Tunisia(5.5), UK(1.6,2.3),
SA(1.7,3.8,4.2,4.95,11.6). Valve replacement was per-
ormed on 30%(mean) and 29%(median) of IE cases.Stroke
ccured in 15%(mean)and 14%(median).Mortality occured
n 23%(mean) and 21%(median) of cases. Bias secondary
o incomplete data, non representative populations, and
issing data for national or regional populations remain
mportant challenge. Speciﬁc strategies to address this lim-
tation are ongoing and include (1) translating non-English
tudies (2) searching the gray literature; and (3) contacting
E experts in world regions with limited or no data.
Conclusion: A comprehensive and systematic assessment
f the global burden and trends in IE mortality and disability
sing a rigorous methodology is being conducted. IE is a rel-
tively uncommon disease but is associated with signiﬁcant
orbidity and mortality. Completion of this effort will add
ubstantively to the summary estimates of cardiovascular
ortality and disability.
oi:10.1016/j.ijid.2010.02.1615
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soas abscess in Korea: Etiology, clinical features, treat-
ent and outcome
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Background: Abscess of the psoas muscle is a rare dis-
ase. Because of nonspeciﬁc presentation, it is difﬁcult to
iagnosis. There is a wide spectrum in etiology, time to diag-
osis, and therapeutic options. This study is to describe the
tiology, clinical features, treatment, and outcome of psoas
bscess from multicenter in Korea.
Methods: We retrospectively reviewed the medical
ecords of patients with psoas muscle abscess who were
dmitted to three university hospitals in Korea over 10 years.
Results: A total of 87 patients (46 male, 41 female) were
ncluded in this study. The mean age was 56.3± 18.5 years
ld. The mean duration of hospitalization was 31.9± 24.37
